We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Bruker Completes Acquisition of Alicona Imaging

By HospiMedica International staff writers
Posted on 31 Dec 2018
Bruker Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Alicona Imaging GmbH (Raaba, Austria), a provider of optical-based metrology products.

Bruker provides scientific instruments and high-value analytical and diagnostic solutions that enable scientists to explore life and materials at the molecular, cellular and microscopic levels. More...
The company’s products and solutions find application in life science molecular research, pharma, microscopy and nanoanalysis, industrial, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. Alicona is a supplier of optical 3D surface measurement solutions for quality assurance in the lab and in production. Its key competence lies in the measurement of form and roughness of even complex, miniaturized geometries.

Alicona's optical 3D metrology products complement Bruker's microCT, stylus profiler, white-light interferometry and atomic force microscope (AFM) product suite. The combined product offering broadens Bruker's application reach and offers customers an even more comprehensive selection of complementary metrology solutions to serve their materials research, engineering and high-precision quality assurance needs.

"We are excited to add Alicona's unique technologies and strong brand to our set of metrology systems," said Dr. Mark R. Munch, Bruker NANO Group President. "Alicona has led the industry in the development of focus variation technology and has delivered high-quality metrology products and manufacturing QA/QC solutions to the market that align nicely with our own products and our strengths in industrial metrology."

"We are very pleased to join Bruker," added Dr. Stefan Scherer, co-CEO of Alicona. "We have built a strong company that delivers superior measurement solutions in laboratory and production environments, and we are looking forward to leveraging Bruker's global reach to serve an even wider customer base and help expand the Bruker portfolio to a wider set of manufacturing solutions."


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Gynecological Examination Chair
arco-matic
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.